vs
MADRIGAL PHARMACEUTICALS, INC.（MDGL）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
MADRIGAL PHARMACEUTICALS, INC.的季度营收约是ROGERS CORP的1.6倍（$321.1M vs $200.5M），ROGERS CORP净利率更高（2.2% vs -18.2%，领先20.5%），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs 5.2%），ROGERS CORP自由现金流更多（$1.1M vs $-133.8M）
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
MDGL vs ROG — 直观对比
营收规模更大
MDGL
是对方的1.6倍
$200.5M
营收增速更快
MDGL
高出205.5%
5.2%
净利率更高
ROG
高出20.5%
-18.2%
自由现金流更多
ROG
多$134.9M
$-133.8M
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $321.1M | $200.5M |
| 净利润 | $-58.6M | $4.5M |
| 毛利率 | — | 32.2% |
| 营业利润率 | -18.6% | — |
| 净利率 | -18.2% | 2.2% |
| 营收同比 | 210.8% | 5.2% |
| 净利润同比 | 1.4% | 421.4% |
| 每股收益（稀释后） | $-2.55 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDGLROG
| Q1 26 | — | $200.5M | ||
| Q4 25 | $321.1M | $201.5M | ||
| Q3 25 | $287.3M | $216.0M | ||
| Q2 25 | $212.8M | $202.8M | ||
| Q1 25 | $137.3M | $190.5M | ||
| Q4 24 | $103.3M | $192.2M | ||
| Q3 24 | $62.2M | $210.3M | ||
| Q2 24 | — | $214.2M |
净利润MDGLROG
| Q1 26 | — | $4.5M | ||
| Q4 25 | $-58.6M | $4.6M | ||
| Q3 25 | $-114.2M | $8.6M | ||
| Q2 25 | $-42.3M | $-73.6M | ||
| Q1 25 | $-73.2M | $-1.4M | ||
| Q4 24 | $-59.4M | $-500.0K | ||
| Q3 24 | $-107.0M | $10.7M | ||
| Q2 24 | — | $8.1M |
毛利率MDGLROG
| Q1 26 | — | 32.2% | ||
| Q4 25 | — | 31.5% | ||
| Q3 25 | — | 33.5% | ||
| Q2 25 | — | 31.6% | ||
| Q1 25 | 96.7% | 29.9% | ||
| Q4 24 | — | 32.1% | ||
| Q3 24 | — | 35.2% | ||
| Q2 24 | — | 34.1% |
营业利润率MDGLROG
| Q1 26 | — | — | ||
| Q4 25 | -18.6% | 3.5% | ||
| Q3 25 | -39.7% | 7.3% | ||
| Q2 25 | -22.2% | -33.3% | ||
| Q1 25 | -57.8% | -0.2% | ||
| Q4 24 | -64.8% | -6.6% | ||
| Q3 24 | -187.1% | 6.9% | ||
| Q2 24 | — | 5.3% |
净利率MDGLROG
| Q1 26 | — | 2.2% | ||
| Q4 25 | -18.2% | 2.3% | ||
| Q3 25 | -39.8% | 4.0% | ||
| Q2 25 | -19.9% | -36.3% | ||
| Q1 25 | -53.4% | -0.7% | ||
| Q4 24 | -57.5% | -0.3% | ||
| Q3 24 | -172.0% | 5.1% | ||
| Q2 24 | — | 3.8% |
每股收益（稀释后）MDGLROG
| Q1 26 | — | $0.25 | ||
| Q4 25 | $-2.55 | $0.20 | ||
| Q3 25 | $-5.08 | $0.48 | ||
| Q2 25 | $-1.90 | $-4.00 | ||
| Q1 25 | $-3.32 | $-0.08 | ||
| Q4 24 | $-2.50 | $-0.04 | ||
| Q3 24 | $-4.92 | $0.58 | ||
| Q2 24 | — | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $198.7M | $195.8M |
| 总债务越低越好 | $339.9M | — |
| 股东权益账面价值 | $602.7M | $1.2B |
| 总资产 | $1.3B | $1.4B |
| 负债/权益比越低杠杆越低 | 0.56× | — |
8季度趋势，按日历期对齐
现金及短期投资MDGLROG
| Q1 26 | — | $195.8M | ||
| Q4 25 | $198.7M | $197.0M | ||
| Q3 25 | $295.7M | $167.8M | ||
| Q2 25 | $186.2M | $157.2M | ||
| Q1 25 | $183.6M | $175.6M | ||
| Q4 24 | $100.0M | $159.8M | ||
| Q3 24 | $232.7M | $146.4M | ||
| Q2 24 | — | $119.9M |
总债务MDGLROG
| Q1 26 | — | — | ||
| Q4 25 | $339.9M | — | ||
| Q3 25 | $339.8M | — | ||
| Q2 25 | $118.4M | — | ||
| Q1 25 | $118.0M | — | ||
| Q4 24 | $117.6M | — | ||
| Q3 24 | $117.1M | — | ||
| Q2 24 | — | — |
股东权益MDGLROG
| Q1 26 | — | $1.2B | ||
| Q4 25 | $602.7M | $1.2B | ||
| Q3 25 | $625.7M | $1.2B | ||
| Q2 25 | $696.0M | $1.2B | ||
| Q1 25 | $710.6M | $1.3B | ||
| Q4 24 | $754.4M | $1.3B | ||
| Q3 24 | $777.2M | $1.3B | ||
| Q2 24 | — | $1.3B |
总资产MDGLROG
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.3B | $1.4B | ||
| Q3 25 | $1.4B | $1.4B | ||
| Q2 25 | $1.0B | $1.5B | ||
| Q1 25 | $996.6M | $1.5B | ||
| Q4 24 | $1.0B | $1.5B | ||
| Q3 24 | $1.1B | $1.5B | ||
| Q2 24 | — | $1.5B |
负债/权益比MDGLROG
| Q1 26 | — | — | ||
| Q4 25 | 0.56× | — | ||
| Q3 25 | 0.54× | — | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | 0.17× | — | ||
| Q4 24 | 0.16× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-133.5M | $5.8M |
| 自由现金流经营现金流 - 资本支出 | $-133.8M | $1.1M |
| 自由现金流率自由现金流/营收 | -41.7% | 0.5% |
| 资本支出强度资本支出/营收 | 0.1% | 2.3% |
| 现金转化率经营现金流/净利润 | — | 1.29× |
| 过去12个月自由现金流最近4个季度 | — | $70.1M |
8季度趋势，按日历期对齐
经营现金流MDGLROG
| Q1 26 | — | $5.8M | ||
| Q4 25 | $-133.5M | $46.9M | ||
| Q3 25 | $79.8M | $28.9M | ||
| Q2 25 | $-47.1M | $13.7M | ||
| Q1 25 | $-88.9M | $11.7M | ||
| Q4 24 | $-104.5M | $33.7M | ||
| Q3 24 | $-67.0M | $42.4M | ||
| Q2 24 | — | $22.9M |
自由现金流MDGLROG
| Q1 26 | — | $1.1M | ||
| Q4 25 | $-133.8M | $42.2M | ||
| Q3 25 | $79.0M | $21.2M | ||
| Q2 25 | — | $5.6M | ||
| Q1 25 | — | $2.1M | ||
| Q4 24 | $-104.7M | $18.3M | ||
| Q3 24 | $-67.8M | $25.2M | ||
| Q2 24 | — | $8.8M |
自由现金流率MDGLROG
| Q1 26 | — | 0.5% | ||
| Q4 25 | -41.7% | 20.9% | ||
| Q3 25 | 27.5% | 9.8% | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | -101.3% | 9.5% | ||
| Q3 24 | -109.0% | 12.0% | ||
| Q2 24 | — | 4.1% |
资本支出强度MDGLROG
| Q1 26 | — | 2.3% | ||
| Q4 25 | 0.1% | 2.3% | ||
| Q3 25 | 0.3% | 3.6% | ||
| Q2 25 | 0.0% | 4.0% | ||
| Q1 25 | 0.0% | 5.0% | ||
| Q4 24 | 0.2% | 8.0% | ||
| Q3 24 | 1.3% | 8.2% | ||
| Q2 24 | — | 6.6% |
现金转化率MDGLROG
| Q1 26 | — | 1.29× | ||
| Q4 25 | — | 10.20× | ||
| Q3 25 | — | 3.36× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.96× | ||
| Q2 24 | — | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
ROG
暂无分部数据
